G A Pangalis
Overview
Explore the profile of G A Pangalis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
628
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kourtis A, Pangalis G, Borche L, Boussiotis V, Dighiero G, Lymberi P
Leuk Lymphoma
. 2016 Jul;
5(4):255-62.
PMID: 27467848
Sera from 60 patients with non-Hodgkin's lymphomas (NHL) were tested by isoelectric focusing (IEF) and immunoblotting (IB) techniques for the presence of monoclonal or oligoclonal immunoglobulins (Ig). Of the 60...
2.
Kittas C, Korkolopoulou P, Pangalis G, Tsenga A, Boussiotis V, Spandidos D
Leuk Lymphoma
. 2016 Jul;
1(3-4):241-7.
PMID: 27463992
The expression of c-myc oncogene in neoplastic and non-neoplastic lymphoid tissue was studied using the specific monoclonal antibody myc 1-9E10 and the 3 step streptavidin-biotin immunoperoxidase method in paraffin sections....
3.
Papaphilis A, Kamper E, Grammenou S, Kattamiss C, Pangalis G
Leuk Lymphoma
. 2016 Jul;
1(3-4):209-20.
PMID: 27463988
A new biological parameter (ψ) has been obtained and proposed here to serve in the assessment of acute myeloid leukemia (AML) progression. It is a function of the activity of...
4.
Lugassy G, Boussiotis V, Ruchlemer R, Pangalis G, Berrebi A, Polliack A
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:179-82.
PMID: 27463503
We describe six rare patients with B-type CLL under the age of 30 years. All were males and four showed a relatively aggressive clinical course requiring initial chemotherapy at an...
5.
Pangalis G, Reverter J, Boussiotis V, Montserrat E
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:175-8.
PMID: 27463502
Whether all younger adult patients with chronic lymphocytic leukemia (CLL) should be offered intensive and/or experimental treatments is currently undecided. In order to investigate the natural history and prognosis of...
6.
Boussiotis V, Panayiotidis P, Pangalis G
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:113-7.
PMID: 27463491
In the present study we investigated whether prolonged intermittent chlorambucil (Chl) administration is more effective for B-chronic lymphocytic leukemia (B-CLL) patients, compared to the traditional mode of shorter duration. One...
7.
Vassilakopoulos T, Papageorgiou S, Pangalis G, Chatziioannou S, Angelopoulou M, Panayiotidis P, et al.
Leukemia
. 2016 Jun;
30(8):1800-1.
PMID: 27256701
No abstract available.
8.
Vassilakopoulos T, Pangalis G, Chatziioannou S, Papageorgiou S, Angelopoulou M, Galani Z, et al.
Leukemia
. 2015 May;
30(1):238-42.
PMID: 25971363
No abstract available.
9.
Palaiologou D, Panayiotidis P, Papanikolaou G, Georgiou G, Boutsikas G, Hatzinicolaou S, et al.
Int J Lab Hematol
. 2014 May;
37(1):e7-e10.
PMID: 24809224
No abstract available.
10.
Yiakoumis X, Pangalis G, Kyrtsonis M, Vassilakopoulos T, Kontopidou F, Kalpadakis C, et al.
Anticancer Res
. 2010 Feb;
30(1):271-6.
PMID: 20150647
Primary effusion lymphoma (PEL) is a rare non-Hodgkin's lymphoma (NHL) mostly occurring in HIV-positive patients. It is characterized by the development of effusion in one or more body cavities, with...